Microbiome Resource Center

Microbiome Resource Center

Issue: February 2021
Source: Healio Interview
Disclosures: Cutcliffe reports being CEO and co-founder of Pendulum Therapeutics.
December 28, 2020
1 min watch
Save

VIDEO: Probiotic drops glucose by 30% in type 2 diabetes

Issue: February 2021
Source: Healio Interview
Disclosures: Cutcliffe reports being CEO and co-founder of Pendulum Therapeutics.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this exclusive video, Colleen Cutcliffe, PhD, CEO and co-founder of Pendulum Therapeutics, discussed two strains of probiotics that the company is currently looking at. Patients with type 2 diabetes are missing strains to enable metabolizing fiber and albuterate and to regulate the mucin layer. Cutcliffe said Pendulum has developed a probiotic, which in a randomized placebo-controlled trial showed efficacy is patients with type 2 diabetes and dropped glucose by 30%.